Cargando…
Symptomatic Heart Failure in Acute Leukemia Patients Treated With Anthracyclines
OBJECTIVES: The purpose of this study was to investigate the occurrence and develop a risk score for heart failure (HF) in acute leukemia. BACKGROUND: Knowledge is scarce regarding the incidence and risk factors of symptomatic HF in patients with acute leukemia. METHODS: Baseline clinical and echoca...
Autores principales: | Kang, Yu, Assuncao, Bruna Leal, Denduluri, Srinivas, McCurdy, Shannon, Luger, Selina, Lefebvre, Bénédicte, Carver, Joseph, Scherrer-Crosbie, Marielle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472996/ https://www.ncbi.nlm.nih.gov/pubmed/32905430 http://dx.doi.org/10.1016/j.jaccao.2019.10.008 |
Ejemplares similares
-
The Association of Metformin With Heart Failure in Patients With Diabetes Mellitus Receiving Anthracycline Chemotherapy
por: Onoue, Takeshi, et al.
Publicado: (2023) -
Dose intensity for induction in acute myeloid leukemia: what, when, and for whom?
por: McCurdy, Shannon R., et al.
Publicado: (2021) -
Cardiovascular Effects of CAR T Cell Therapy: A Retrospective Study
por: Lefebvre, Bénédicte, et al.
Publicado: (2020) -
Circulating hemopexin modulates anthracycline cardiac toxicity in patients and in mice
por: Liu, Jing, et al.
Publicado: (2022) -
Harnessing allogeneic NK cells: improving outcomes with tailored donor lymphocyte infusion
por: McCurdy, Shannon R.
Publicado: (2022)